Skip to main content
Philogen logo

Philogen — Investor Relations & Filings

Ticker · PHIL ISIN · IT0005373789 LEI · 81560009EA1577917768 XMIL Manufacturing
Open in API
Filings indexed 375 across all filing types
Latest filing 2026-01-19 Transaction in Own Shar…
Country IT Italy
Listing XMIL PHIL

About Philogen

https://www.philogen.com

Philogen is a clinical-stage biotechnology company focused on the discovery and development of novel biopharmaceutical products for the treatment of cancer and other serious conditions associated with angiogenesis. Founded in 1996, the company's core strategy is based on innovating targeted therapies, such as antibody-cytokine fusions, which are designed to selectively deliver therapeutic agents to the site of disease. This approach aims to increase efficacy while reducing toxicity. Philogen operates as an integrated company with capabilities in research, GMP manufacturing, and clinical development of its proprietary product pipeline.

Recent filings

Filing Released Lang Actions
2026 01 19 - CS settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from Philogen S.p.A. regarding the execution of a share buyback program. It details the number of shares purchased, the price, and the dates of the transactions, including a granular table of individual trades. This falls under the category of 'Transaction in Own Shares' (POS), which covers share repurchases.
2026-01-19 Italian
Allegato 3F
Director's Dealing Classification · 98% confidence The document is a formal disclosure form titled 'Model Disclosure for Transactions in the Issuer's Securities' (Schema di Comunicazione delle Operazioni sui Titoli dell'Emittente). It details specific share transactions (purchase of 4,000 shares) by an entity (Mediobanca) in relation to the issuer (Philogen S.p.A.). This is a standard regulatory disclosure for share transactions, which falls under the category of 'Transaction in Own Shares' or related insider/entity dealing disclosures. Given the specific nature of the form (Annex 3F), it is a report of transactions in the issuer's securities.
2026-01-09 Italian
2025 12 09 - CS Settimanale acquisto azioni proprie
Transaction in Own Shares Classification · 100% confidence The document is a formal announcement from Philogen S.p.A. regarding the execution of a share buyback program ('programma di acquisto di azioni proprie'). It details the number of shares purchased, the average price, the total value, and provides a granular table of daily transactions. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2025-12-09 Italian
The Board of Directors approves the financial position for the third quarter of 2025
Earnings Release Classification · 98% confidence The document is a press release from Philogen S.p.A. detailing the company's net financial position for Q3 2025, providing a breakdown of financial indebtedness, and offering a comprehensive update on the status of various clinical trials (Nidlegy, Fibromun, OncoFAP, etc.). While it contains financial data, it is not a full quarterly report (IR) but rather a management-led announcement of results and operational progress. It fits the definition of a Management Report (MDA) as it provides management's detailed explanation of financial results, business trends, and outlook. Q3 2025
2025-11-11 English
Il Consiglio di Amministrazione approva la Posizione Finanziaria Netta relativa al Terzo Trimestre 2025
Earnings Release Classification · 96% confidence The document is a formal announcement from Philogen S.p.A. regarding the approval of the net financial position for the third quarter of 2025 by the Board of Directors. It includes detailed financial tables (Net Financial Indebtedness) and a comprehensive update on the company's clinical trials (Nidlegy, Fibromun, OncoFAP). While it contains financial data, it is an initial announcement of quarterly results and operational progress rather than a full, audited quarterly report. Therefore, it is classified as an Earnings Release (ER). Q3 2025
2025-11-11 Italian
Allegato 3F
Transaction in Own Shares Classification · 100% confidence The document is a standardized regulatory form titled 'SCHEMA DI COMUNICAZIONE DELLE OPERAZIONI SUI TITOLI DELL'EMITTENTE' (Model Disclosure for Transactions in the Issuer's Securities). It details specific daily transactions (purchases) of Philogen S.p.A. shares conducted by Mediobanca. This type of disclosure, where a company reports its own share buybacks or transactions in its own securities, is classified as 'Transaction in Own Shares' (POS).
2025-11-10 Italian

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.